MQS Management LLC Acquires Shares of 7,659 Prestige Consumer Healthcare Inc. (NYSE:PBH)

MQS Management LLC purchased a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,659 shares of the company's stock, valued at approximately $552,000.

Several other large investors have also recently bought and sold shares of the company. Opal Wealth Advisors LLC bought a new stake in shares of Prestige Consumer Healthcare in the second quarter worth $26,000. Quest Partners LLC grew its position in shares of Prestige Consumer Healthcare by 2,826.7% in the 2nd quarter. Quest Partners LLC now owns 439 shares of the company's stock valued at $30,000 after buying an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company's stock valued at $33,000 after purchasing an additional 208 shares during the period. Gladius Capital Management LP acquired a new stake in shares of Prestige Consumer Healthcare during the second quarter worth $35,000. Finally, Northwestern Mutual Wealth Management Co. raised its position in shares of Prestige Consumer Healthcare by 562.3% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company's stock worth $35,000 after acquiring an additional 433 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Stock Up 0.6 %

PBH stock traded up $0.49 during midday trading on Thursday, reaching $82.81. 337,716 shares of the company's stock traded hands, compared to its average volume of 250,663. The company has a market cap of $4.09 billion, a price-to-earnings ratio of 20.05, a P/E/G ratio of 2.30 and a beta of 0.47. The firm's fifty day moving average price is $72.98 and its 200-day moving average price is $70.09. Prestige Consumer Healthcare Inc. has a 52 week low of $56.61 and a 52 week high of $83.83. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported $1.09 EPS for the quarter, hitting the consensus estimate of $1.09. The firm had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The company's quarterly revenue was down .9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.07 earnings per share. As a group, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on PBH shares. DA Davidson reiterated a "buy" rating and issued a $95.00 price objective on shares of Prestige Consumer Healthcare in a research note on Monday. Jefferies Financial Group reiterated a "hold" rating and set a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, Prestige Consumer Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.